Prenatal liver stromal cells: Favorable feeder cells for long‐term culture of hepatic progenitor cells

Abstract

Clinical and pharmaceutical applications of primary hepatocytes (PHs) are limited due to inadequate number of donated livers and potential challenges in successful maintenance of PHs in culture. Freshly isolated hepatocytes lose their specific features and rapidly de‐differentiate in culture. Bipotent hepatoblasts, as liver precursor cells that can differentiate into both hepatocytes and cholangiocytes (Alb‐ and Ck19‐positive cells, respectively), could be used as an alternative and reliable cell source to produce enough PHs for drug discovery or possible clinical applications. In this study, growth factor‐free coculture systems of prenatal or postnatal murine liver stromal cells (pre‐LSCs or post‐LSCs, respectively) were used as feeder cells to support freshly isolated mice hepatoblasts. DLK1‐positive hepatoblasts were isolated from mouse fetuses (E14.5) and cocultured with feeder cells under adherent conditions. The hepatoblasts' bipotent features, proliferation rate, and colony formation capacity were assessed on day 5 and 7 post‐seeding. Immunofluorescence staining showed that the hepatoblasts remained double positive for Alb and Ck19 on both Pre‐ and Post‐LSCs, after 5 and 7 days of coculture. Moreover, application of pre‐LSCs as feeder cells significantly increased the number of DLK1‐positive cells and their proliferation rate (ie, increased the number of Ki‐67 positive cells) on day 7, compared to Post‐LSCs group. Finally, to address our ultimate goal, which was an extension of hepatoblasts ex vivo maintenance, 3D spheres of isolated hepatoblasts were, cultured in conditioned medium (CM) derived from pre‐LSCs until day 30. It was observed that the CM derived from Pre‐LSCs could successfully prolong the maintenance of hepatic progenitor cells (HPCs) in 3D suspension culture.

Generation of Transplantable Three-Dimensional Hepatic-Patch to Improve the Functionality of Hepatic Cells In Vitro and In Vivo

“…Primary human hepatocytes (PHHs) are the best candidate for the all mentioned applications. Unfortunately, the PHHs are not always available and they do not proliferate in vitro and rapidly dedifferentiate [7][8][9][10]. In vitro-differentiated hepatocyte-like cells (HLCs) derived from pluripotent stem cells, as an alternative cell source, are not mature enough and are very expensive and challenging [4,11].…”